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Diminished parasympathetic influence is central to the pathogenesis of cardiovascular
diseases, including heart failure and hypertension. Stimulation of the vagus nerve
has shown promise in treating cardiovascular disease, prompting renewed interest in
understanding the signaling pathway(s) that mediate the vagal influence on cardiac
physiology. Here, we evaluated the contribution of G protein-gated inwardly rectifying K+
(GIRK/Kir3) channels to the effect of vagus nerve stimulation (VNS) on heart rate (HR),
HR variability (HRV), and arrhythmogenesis in anesthetized mice. As parasympathetic
fibers innervate both atria and ventricle, and GIRK channels contribute to the cholinergic
impact on atrial and ventricular myocytes, we collected in vivo electrocardiogram
recordings from mice lacking either atrial or ventricular GIRK channels, during VNS. VNS
decreased HR and increased HRV in control mice, in a muscarinic receptor-dependent
manner. This effect was preserved in mice lacking ventricular GIRK channels, but was
nearly completely absent in mice lacking GIRK channels in the atria. In addition, atrial-
specific ablation of GIRK channels conferred resistance to arrhythmic episodes induced
by VNS. These data indicate that atrial GIRK channels are the primary mediators of the
impact of VNS on HR, HRV, and arrhythmogenesis in the anesthetized mouse.
Keywords: atrial, vagus nerve stimulation, parasympathetic, arrhythmogenesis, GIRK channel, Kir3
INTRODUCTION
The parasympathetic and sympathetic branches of the autonomic nervous system work
antagonistically to maintain cardiovascular homeostasis (Gordan et al., 2015). Autonomic
dysregulation, characterized by excessive sympathetic activation and diminished parasympathetic
influence, is central to the pathogenesis of cardiovascular diseases including heart failure and
hypertension (Bibevski and Dunlap, 2011; Schwartz and De Ferrari, 2011; Mancia and Grassi,
2014). Efferent fibers of the vagus nerve provide the parasympathetic innervation to the heart, and
vagus nerve stimulation (VNS) has shown promise in the treatment of cardiovascular diseases,
including heart failure and hypertension (Xie et al., 2014; Beaumont et al., 2015; Petkovich
et al., 2015; Premchand et al., 2016; Smith et al., 2016). As a result, there is renewed interest in
understanding the cell signaling pathways that mediate the impact of VNS on cardiac physiology.
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Parasympathetic regulation of heart rate (HR) is mediated
via release of acetylcholine (ACh), which activates cardiac
muscarinic M2 receptors (M2R) on sinoatrial and atrioventricular
nodal cells, and atrial myocytes (Dhein et al., 2001). M2R
activation stimulates inhibitory G proteins, which suppress the
activity of the HCN (pacemaker or “funny” current, If) and
L-type Ca2+ channels (ICa,L) (DiFrancesco et al., 1989; Zaza et al.,
1996; DiFrancesco and Borer, 2007; Mangoni and Nargeot, 2008;
DiFrancesco, 2010; Kozasa et al., 2018), and activate G protein-
gated inwardly rectifying K+ (GIRK/Kir3) channels (Logothetis
et al., 1987; Wickman et al., 1994; Dhein et al., 2001). The atrial
GIRK channel, often referred to as IKACh, is a heterotetrameric
complex composed of homologous subunits – GIRK1/Kir3.1
and GIRK4/Kir3.4 – in 1:1 stoichiometry (Krapivinsky et al.,
1995; Corey et al., 1998). Ventricular myocytes also express
a GIRK1/GIRK4 channel, albeit at lower levels than in atrial
myocytes, and this channel mediates the impact of cholinergic
agonists on action potential duration and the excitability of
ventricular myocytes (Koumi et al., 1997; Dobrzynski et al., 2001,
2002; Posokhova et al., 2010; Liang et al., 2014; Anderson et al.,
2018).
The extent to which the various cardiac conductances
(If, ICa,L, GIRK) contribute to the parasympathetic influence on
HR dynamics is unclear. Previous studies investigating the role
of GIRK channels have used pharmacological tools to mimic
parasympathetic activation in constitutive/global knockout mice
lacking either GIRK1 (Girk1−/−; Bettahi et al., 2002) or GIRK4
(Girk4−/−; Wickman et al., 1998). Loss of either subunit
eliminates the GIRK current in atria and ventricular myocytes
(Wickman et al., 1998; Bettahi et al., 2002; Mesirca et al.,
2013; Posokhova et al., 2013; Anderson et al., 2018), and
yields a comparable attenuation of HR responses to systemic
administration of parasympathomimetic agents (Bettahi et al.,
2002). For example, experiments involving the administration
of the α1 adrenergic receptor agonist methoxamine, which
evokes a baroreflex-mediated increase in parasympathetic input
to the heart, suggested that GIRK channel activation accounts
for approximately half of the bradycardic effect of indirect
parasympathetic activation in awake mice (Wickman et al., 1998;
Bettahi et al., 2002). While direct perfusion of isolated hearts from
wild-type and Girk4−/− mice with relatively high concentrations
of ACh (0.3–10 µM) yielded similar results, the bradycardic effect
of lower ACh concentrations was comparable in these hearts
(Mesirca et al., 2013). Thus, the mediators of parasympathetic
influence on HR dynamics may differ depending on the type and
intensity of pharmacological stimulation, and the model systems
used to evaluate their impact.
While the vagal nerve innervation of atrial and nodal tissue
is well-established, vagal innervation of the ventricle has also
been reported (Coote, 2013). The relative contribution of atrial
and ventricular GIRK channels to the parasympathetic regulation
of the heart has not been fully elucidated. Moreover, GIRK1
and GIRK4 are expressed in the hypothalamus, and GIRK4 has
been detected specifically in the paraventricular nucleus of the
hypothalamus (Karschin et al., 1996; Wickman et al., 2000; Perry
et al., 2008; Lujan and Aguado, 2015), a region that regulates
cardiac vagal neurons in the brainstem (Pinol et al., 2014;
Dyavanapalli et al., 2016). Thus, the impact of Girk1 or Girk4
ablation on HR dynamics following pharmacological stimulation
of the baroreflex could be due to loss of GIRK channel activity
in a central regulator(s) of autonomic function. In this study,
we used direct VNS, and new atrial- and ventricle-specific
models of GIRK channel ablation, to probe the contribution
of cardiac GIRK channels to the parasympathetic regulation of
HR, HR variability (HRV), and arrhythmogenesis. Our findings
suggest that the impact of direct VNS on cardiac physiology in




All experiments were performed in accordance with the
guidelines set forth by the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and
were approved by the University of Minnesota Institutional
Animal Care and Use Committee. C57BL/6J mice and B6.Cg-
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J (Ai14-tdTomato)
reporter mice were purchased from The Jackson Laboratory
(Bar Harbor, ME, United States). The generation of constitutive
Girk4−/− mice, as well as mice lacking GIRK1 in ventricular
tissue (MLC2VCre(+):Girk1fl/fl) and their control littermates
(MLC2VCre(−):Girk1fl/fl), was described previously (Wickman
et al., 1998; Anderson et al., 2018). To generate mice lacking
GIRK1 in atrial tissue, conditional Girk1 knockout mice
(Girk1fl/fl mice; Marron Fernandez de Velasco et al., 2017)
were crossed with an atrial-specific Cre driver line (SLNCre
mice; Nakano et al., 2011). SLNCre(+):Girk1fl/fl mice, and
their control littermates (SLNCre(−):Girk1fl/fl), were used in
this study. All mice were housed in a quiet, temperature- and
humidity-controlled room with a 12:12 h light-dark cycle. Food
and water were available ad libitum.
Microscopy
Mice were injected intraperitoneally (IP) with heparin (250 U)
and then anesthetized with ketamine (100 mg/kg) and xylazine
(10 mg/kg). Hearts were then excised, fixed, and sectioned
as described (Anderson et al., 2018). Once sections were
mounted and stained with ProLong Gold Antifade reagent with
DAPI (Thermo Fisher Scientific, Waltham, MA, United States),
fluorescent images were captured and processed as described
(Anderson et al., 2018).
Cardiomyocyte Culture and
Electrophysiology
Adult (8–12 weeks) sinoatrial nodal (SAN) cells and ventricular
myocytes were isolated as described (Anderson et al., 2018) and
used within 8 h of isolation. Coverslips containing SAN cells or
ventricular myocytes were transferred to a perfusion chamber
and electrophysiological recordings were conducted as described
(Anderson et al., 2018). In brief, whole-cell access was obtained
in a bath consisting of (in mM): 130 NaCl, 5.4 KCl, 1 CaCl2,
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1 MgCl2, 5.5 glucose, 5 HEPES/NaOH (pH 7.4). CCh-currents
(holding potential of−70 mV) were measured in a high-K+ bath
solution consisting of (in mM): 120 NaCl, 25 KCl, 1 CaCl2, 1
MgCl2, 5.5 glucose, 5 HEPES/NaOH (pH 7.4). CCh was applied
via ValveLink 8.2 rapid perfusion system (AutoMate Scientific,
Berkeley, CA, United States). BaCl2 (5 µM) was included in
the bath solution for ventricular myocyte recordings to block
IK1, which has been shown to mask GIRK-dependent currents
(Beckmann et al., 2008). Studies using these recording conditions,
and Girk1−/− and/or Girk4−/− mice, have shown definitively
that the inward currents evoked by cholinergic agonists are
mediated entirely by GIRK channel activation (Bettahi et al.,
2002; Posokhova et al., 2013; Anderson et al., 2018). Steady-state
CCh-induced currents (pA) were normalized to cell capacitance
(pF), and experiments that did not have stable, low access
resistances (<20 M) were not included.
ECG Recordings in SLNCre:Girk1fl/fl
Mice
Male and female SLNCre(−):Girk1fl/fl and SLNCre(+):Girk1fl/fl
mice (8–12 weeks) were anesthetized with 1.5% isoflurane
supplemented with an air mixture of 40% O2/60% N2 to
sustain stable HR. ECG electrodes were placed subcutaneously
into the limbs, and ECG data were acquired with an
IX-ECG-12 ECG recorder (iWorx Systems, Inc., Dover, NH,
United States). Baseline ECG data were recorded for 10 min,
at which point the non-selective cholinergic agonist carbachol
(CCh) was administered (1.0 mg/kg IP). Baseline (9–10 min)
and post-CCh (15–16 min) HR and HRV analysis was
performed using Kubios HRV software (Tarvainen et al., 2014).
Artifact detection/correction was utilized to detect RR intervals
and reduce the impact of ectopic beats and instances of
atrioventricular block on HR and HRV analysis.
Vagus Nerve Bipolar Cuff Electrode
Implantation and ECG Recording
Male and female mice (8–12 weeks) were anesthetized with
isoflurane (5% for induction and 1.5% for maintenance). After
hair removal and skin cleaning, aseptic technique was used
to make a ventral midline incision in the neck, and the skin
and muscles were retracted. After identifying and isolating the
right vagus nerve, a custom helical lead bipolar cuff electrode
(Cyberonics, Inc., Houston, TX, United States) was implanted
around the nerve (Xie et al., 2014; Lee et al., 2016). The electrode
was then connected to the Demipulse Model 103 VNS pulse
generator (Cyberonics, Inc.). For VNS experiments, 1 min of
baseline ECG was recorded (PRE). Subsequently, VNS (0.25 mA,
10 Hz, and 500 µs) was delivered for 1 min (ON). ECG data
were then acquired for 1 min immediately after VNS cessation
(POST). Each experiment concluded with PRE, ON, and POST
ECG measurements conducted 10 min after administration of
atropine (2.0 mg/kg IP).
Analysis of VNS ECG Recordings
ECG recordings were used to quantify changes in HR and HRV
due to VNS throughout the study using Kubios HRV software.
All values were averaged over 1 min PRE and ON periods of VNS
stimulation. Noisy data segments, premature atrial complexes,
and arrhythmic episodes were excluded, and only steady-state
data after initial adjustment of the HR to VNS were used for
analysis. To account for inter-subject variations in baseline HR,
the chronotropic effect of VNS was determined by calculating a







where HRON and HRPRE are the mean HR during the VNS ON
and PRE periods, respectively. HRV was calculated as the ratio
between the standard deviation of RR intervals (SDRR) to mean







The number of mice that exhibited arrhythmic episodes was also
quantified during both PRE and ON periods. An arrhythmic
episode was defined as any of the following episodes: (i) skipped
beats, (ii) bigeminy, (iii) bradycardia (HR at least 25 bpm less
than the mean PRE or ON HR, lasting for more than 2 s), and
(iv) tachycardia (HR at least 25 bpm more than the mean PRE or
ON HR, lasting for more than 2 s). Premature atrial complexes
were not considered arrhythmic episodes as they were observed
during VNS regardless of genotype, and frequently occur under
healthy conditions (Shindler and Kostis, 2009).
Statistical Analysis
All data are presented as mean ± SEM. Student’s t-test, two-
way ANOVA with repeated measures, and Fisher’s exact test
were used as appropriate (GraphPad Software, Inc., La Jolla, CA,
United States). For studies involving two-way ANOVA analysis,
interactions are reported if detected. Post hoc analysis (Bonferroni
multiple comparison) was used when appropriate. The level of
significance was set at P < 0.05.
RESULTS
Generation and Characterization of an
Atrial-Specific Girk−/− Mouse Line
In a recent study, we reported the development and
characterization of a ventricle-specific Girk1−/− mouse
(MLC2VCre:Girk1fl/fl) that lacked ventricular GIRK channel
activity (Anderson et al., 2018). To generate an atrial-specific
Girk1−/− line, we crossed conditional Girk1 knockout mice
(Girk1fl/fl; Marron Fernandez de Velasco et al., 2017) with an
atrial-specific Cre driver line (SLNCre; Nakano et al., 2011).
The atrial specificity of Cre-dependent recombination in the
SLNCre driver line was validated by crossing this line with a
Cre-dependent fluorescent reporter mouse (Ai14-tdTomato)
(Figures 1A,B).
To test whether atrial GIRK channel activity was lost
in SLNCre(+):Girk1fl/fl mice, we measured whole-cell
currents evoked by CCh in SAN cells from adult Cre(+)
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FIGURE 1 | Characterization of an atrial-specific Girk−/− mouse line. (A,B) SLNCre(–) and SLNCre(+) mice were crossed with the Cre-dependent fluorescent
reporter strain, Ai14-tdTomato. Representative sections stained with DAPI (Left), and associated tdTomato fluorescence (Right), in hearts from SLNCre(–) (Top) and
SLNCre(+) (Bottom) offspring. (C) Representative whole-cell currents (Vhold = –70 mV) evoked by carbachol (CCh, 10 µM) in a high-K+ bath solution in adult SAN
cells from SLNCre(–):Girk1fl/fl and SLNCre(+):Girk1fl/fl mice. Scale bars: 1 nA/10 s. (D,E) Summary of CCh-induced currents in adult SAN cells (t47 = 11.3;
∗∗∗P < 0.001; n = 24–25/genotype) and ventricular myocytes (VM; t21 = 0.6; P = 0.54; n = 11–12/genotype) from SLNCre(–):Girk1fl/fl and SLNCre(+):Girk1fl/fl mice.
and Cre(−) littermates. CCh-induced current density was
significantly smaller in SAN cells from SLNCre(+):Girk1fl/fl
mice when compared to SLNCre(−):Girk1fl/fl littermates
(Figures 1C,D). The small residual CCh-induced current
seen in SLNCre(+):Girk1fl/fl SAN cells is likely due to the
presence of residual GIRK4 homomeric channels (Corey
and Clapham, 1998). Importantly, CCh-induced current
densities were comparable in adult ventricular myocytes from
SLNCre(+):Girk1fl/fl and SLNCre(−):Girk1fl/fl mice (Figure 1E).
Constitutive Girk1−/− and Girk4−/− mice exhibit
blunted HR and HRV responses to cholinergic agonists
(Wickman et al., 1998; Kovoor et al., 2001; Bettahi et al.,
2002; Anderson et al., 2018). To discern whether these
effects are mediated by activation of atrial GIRK channels,
we recorded ECGs in anesthetized SLNCre(−):Girk1fl/fl and
SLNCre(+):Girk1fl/fl mice, before and after administration of
CCh (1.0 mg/kg IP) (Figure 2A). We observed no differences
in baseline HR or HRV between SLNCre(−):Girk1fl/fl and
SLNCre(+):Girk1fl/fl mice (Figures 2B,C). CCh-induced
bradycardia, while present, was smaller in SLNCre(+):Girk1fl/fl
mice than in SLNCre(−):Girk1fl/fl littermates (Figure 2B).
In addition, the CCh-induced increase in HRV in control
SLNCre(−):Girk1fl/fl mice was absent in SLNCre(+):Girk1fl/fl
mice (Figure 2C). Thus, mice lacking atrial GIRK channels
exhibit diminished HR and absent HRV responses to CCh
challenge, reminiscent of phenotypes reported in Girk1−/− and
Girk4−/− mice.
Impact of Whole-Heart and
Tissue-Specific GIRK Channel Ablation
on Baseline HR and HRV
We next evaluated HR and HRV prior to and during acute VNS
in anesthetized SLNCre(+):Girk1fl/fl and SLNCre(−):Girk1fl/fl
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FIGURE 2 | Impact of atrial GIRK channel ablation on HR and HRV responses to carbachol. (A) Representative segments of ECG recordings from anesthetized
SLNCre(–):Girk1fl/fl and SLNCre(+):Girk1fl/fl mice, at baseline (Top) and following administration of CCh (1.0 mg/kg IP; Bottom). (B) Summary of HR data at baseline
(base) and after CCh injection for SLNCre(–):Girk1fl/fl (n = 7) and SLNCre(+):Girk1fl/fl (n = 8) mice. Two-way ANOVA analysis revealed an interaction between
genotype and treatment (F1,13 = 38.6; P < 0.001). Symbols: ∗P < 0.05 and ∗∗∗P < 0.001, vs. baseline (within genotype); ###P < 0.001 vs. SLNCre(–):Girk1fl/fl
(within treatment). (C) Summary of HRV data at baseline (base) and after CCh injection for SLNCre(–):Girk1fl/fl (n = 7) and SLNCre(+):Girk1fl/fl (n = 8) mice. HRV was
calculated as the ratio of standard deviation of RR to mean RR (see section “Materials and Methods”). Two-way ANOVA analysis revealed an interaction between
genotype and treatment (F1,13 = 5.4; P < 0.05). Symbols: ∗P < 0.05 vs. baseline (within genotype); ##P < 0.01 vs. SLNCre(–):Girk1fl/fl mice (within treatment).
mice, and MLC2VCre(+):Girk1fl/fl and MLC2VCre(−):Girk1fl/fl
mice. These studies also involved wild-type and constitutive
Girk4−/− mice, which lack cardiac GIRK channels (whole-heart
ablation). We did not observe a difference in baseline HR or HRV
between wild-type and Girk4−/− mice (Figures 3A,B). Similarly,
there were no significant differences in baseline HR and HRV
between SLNCre(−):Girk1fl/fl and SLNCre(+):Girk1fl/fl mice,
or MLC2VCre(−):Girk1fl/fl and MLC2VCre(+):Girk1fl/fl mice
(Figures 3A,B).
Whole-Heart and Tissue-Specific GIRK
Channel Ablation and VNS-Induced
Bradycardia
We next assessed the impact of whole-heart or tissue-specific
GIRK channel ablation on the bradycardic effects of acute
VNS, by comparing the relative change in HR evoked by VNS
(1HRON). Acute VNS suppressed HR by more than 40%
in anesthetized wild-type mice, but had little impact on HR
in Girk4−/− mice (Figure 4C). SLNCre(+):Girk1fl/fl mice
also displayed minimal VNS-induced bradycardia relative to
SLNCre(−):Girk1fl/fl controls (Figures 4A–C). In contrast,
the VNS-induced decrease in HR was comparable between
MLC2VCre(+):Girk1fl/fl and MLC2VCre(−):Girk1fl/fl mice
(Figure 4C). After VNS was terminated, HR values returned
to baseline for all genotypes (data not shown). To determine
if the bradycardic effect of VNS was dependent on muscarinic
receptor activation, we also evaluated the impact of VNS on
HR following administration of atropine (2.0 mg/kg IP). In the
presence of atropine, VNS had no effect on HR in any of the
genotypes evaluated (Figure 4D). Collectively, these findings
suggest that VNS-induced bradycardia in anesthetized mice is
mediated predominantly by the muscarinic receptor-dependent
activation of atrial GIRK channels.
Whole-Heart and Tissue-Specific GIRK
Channel Ablation and VNS-Induced
Increase in HRV
We next examined the impact of VNS on HRV in whole-
heart and tissue-specific Girk−/− mice. VNS evoked a significant
increase in HRV in wild-type and SLNCre(−):Girk1fl/fl mice,
and this effect was absent in both constitutive Girk4−/−
and SLNCre(+):Girk1fl/fl mice (Figures 5A,B). In contrast,
the increase in HRV induced by VNS was similar in
both MLC2VCre(−):Girk1fl/fl and MLC2VCre(+):Girk1fl/fl mice
(Figure 5B). Atropine blocked the VNS-induced increase in HRV
in wild-type, SLNCre(−):Girk1fl/fl, MLC2VCre(−):Girk1fl/fl, and
MLC2VCre(+):Girk1fl/fl mice (Figure 5C). Thus, the VNS-
induced increase in HRV in mice appears to be mediated
predominantly through the muscarinic receptor-dependent
activation of atrial GIRK channels.
Whole-Heart and Tissue-Specific GIRK
Channel Ablation and VNS-Induced
Arrhythmias
Direct VNS has been utilized extensively in previous
studies to induce and maintain arrhythmias in various
large mammalian species (Zhang and Mazgalev, 2011).
To probe the involvement of GIRK channel activation on
VNS-induced arrhythmogenesis, we quantified arrhythmic
episodes prior to and after VNS in whole-heart and
tissue-specific Girk−/− mice, and their respective controls
(Figure 6). No mice displayed arrhythmic episodes prior
to VNS, nor were arrhythmic episodes seen in mice given
atropine (data not shown). Arrhythmic episodes were
frequently observed, however, during VNS in wild-type
and SLNCre(−):Girk1fl/fl mice (Figure 6B). In contrast,
Girk4−/− and SLNCre(+):Girk1fl/fl mice did not exhibit
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FIGURE 3 | Impact of whole-heart and tissue-specific GIRK channel ablation on baseline HR and HRV. (A) Summary of baseline HR data. There were no significant
differences in baseline HR between wild-type (n = 10) and Girk4−/− (n = 10) mice (t18 = 1.0; P = 0.32), SLNCre(–):Girk1fl/fl (n = 6) and SLNCre(+):Girk1fl/fl (n = 5)
mice (t9 = 1.1; P = 0.29), or MLC2VCre(–):Girk1fl/fl (n = 6) and MLC2VCre(+):Girk1fl/fl (n = 8) mice (t12 = 0.7; P = 0.51). (B) Summary of baseline HRV data. There
were no significant differences in HRV between wild-type (n = 10) and Girk4−/− (n = 10) mice (t18 = 1.2; P = 0.23), SLNCre(–):Girk1fl/fl (n = 5) and SLNCre(+):Girk1fl/fl
(n = 5) mice (t8 = 1.1, P = 0.32), or MLC2VCre(–):Girk1fl/fl (n = 6) and MLC2VCre(+):Girk1fl/fl (n = 8) mice (t12 = 0.32; P = 0.76).
FIGURE 4 | Impact of whole-heart and tissue-specific GIRK channel ablation on VNS-induced decrease in HR. (A,B) Representative ECG segments from
anesthetized SLNCre(–):Girk1fl/fl (Top) and SLNCre(+):Girk1fl/fl (Bottom) mice prior to (PRE, Left), during (ON, Middle), and after (POST, Right) VNS. The small spikes
observed during VNS (ON) correspond to electrical stimulation artifacts. (C) Relative change in HR (1HRON) during VNS. A significant difference in 1HRON was
observed between wild-type (n = 9) and Girk4−/− (n = 10) mice (t17 = 6.5; ∗∗∗P < 0.001), as well as SLNCre(–):Girk1fl/fl (n = 6) and SLNCre(+):Girk1fl/fl (n = 5) mice
(t9 = 3.9; ∗∗P < 0.01). No difference was seen between MLC2VCre(–):Girk1fl/fl (n = 6) and MLC2VCre(+):Girk1fl/fl (n = 8) mice (t12 = 0.95; P = 0.36). (D) Relative
change in HR (1HRON) during VNS, in the presence of atropine (2.0 mg/kg IP). There were no significant differences between wild-type (n = 4) and Girk4−/− (n = 6)
mice (t8 = 0.6; P = 0.59), SLNCre(–):Girk1fl/fl (n = 6) and SLNCre(+):Girk1fl/fl (n = 4) mice (t8 = 0.2; P = 0.82), and MLC2VCre(–):Girk1fl/fl (n = 6) and
MLC2VCre(+):Girk1fl/fl (n = 4) mice (t8 = 0.2, P = 0.88).
VNS-induced arrhythmias (Figure 6B). VNS-induced
arrhythmogenesis was comparable in MLC2VCre(+):Girk1fl/fl
and MLC2VCre(−):Girk1fl/fl mice. Overall, these findings
suggest that atrial GIRK channels play a critical role in the
induction of arrhythmias during VNS.
DISCUSSION
Parasympathetic regulation of cardiac physiology is thought
to involve muscarinic-dependent and independent actions on
atrial and ventricular tissue, and multiple enzymes and ion
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FIGURE 5 | Impact of whole-heart and tissue-specific GIRK channel ablation on VNS-induced increase in HRV. (A) Typical RR tachograms extracted from ECG
recordings while VNS was on, comparing beat-to-beat changes in RR intervals between SLNCre(–):Girk1fl/fl (Top) and SLNCre(+):Girk1fl/fl (Bottom) mice.
(B) Summary of mean HRV data at baseline and during VNS. Two-way ANOVA analysis revealed an interaction between genotype and treatment between wild-type
(n = 8) and Girk4−/− (n = 10) mice (F1,16 = 20.3; P < 0.001), and between SLNCre(–):Girk1fl/fl (n = 6) and SLNCre(+):Girk1fl/fl (n = 5) mice (F1,9 = 12.8; P < 0.01).
There was a significant main effect of treatment (F1,12 = 44.0; P < 0.001) between MLC2VCre(–):Girk1fl/fl (n = 6) and MLC2VCre(+):Girk1fl/fl (n = 8) littermates, but
no main effect of genotype (F1,12 = 4.2; P = 0.06) or interaction between genotype and treatment (F1,12 = 3.2; P = 0.10). Symbols: ∗P < 0.05, ∗∗P < 0.01, and
∗∗∗P < 0.001, vs. PRE (within genotype); ###P < 0.001, wild-type vs. Girk4−/− (within treatment); ##P < 0.01, SLNCre(–):Girk1fl/fl vs. SLNCre(+):Girk1fl/fl (within
treatment). (C) Summary of mean HRV data at baseline and during VNS, following atropine administration. In wild-type (n = 4) and Girk4−/− (n = 6) mice, there was a
main effect of treatment (F1,8 = 5.7, P < 0.05), however, post hoc analysis did not reveal any significance within either genotype. There was no main effect of
genotype (F1,8 = 2.0, P = 0.19), or interaction between genotype and treatment (F1,8 = 3.2; P = 0.11), in wild-type and Girk4−/− mice as well. There was no main
effect of treatment (F1,8 = 0.1, P = 0.76) or genotype (F1,8 = 0.53, P = 0.49), and no interaction between treatment and genotype (F1,8 = 3.5, P = 0.1), in
SLNCre(–):Girk1fl/fl (n = 6) and SLNCre(+):Girk1fl/fl (n = 4) mice. There was no main effect of treatment (F1,7 = 0.45, P = 0.52) or genotype (F1,7 = 0.79, P = 0.40),
and no interaction between treatment and genotype (F1,7 = 0.3; P = 0.62), in MLC2VCre(–):Girk1fl/fl (n = 6) and MLC2VCre(+):Girk1fl/fl (n = 4) mice.
FIGURE 6 | Impact of whole-heart and tissue-specific GIRK channel ablation on VNS-induced arrhythmogenesis. (A) Representative segments of ECG recordings of
arrhythmias (bigeminy, skipped beats, bradycardia, and tachycardia) observed during VNS. (B) Total number of mice exhibiting arrhythmic episodes during VNS.
Fisher’s exact test revealed a significant difference in arrhythmia incidence between wild-type (n = 10) and Girk4−/− (n = 10) mice (∗∗P < 0.01), and
SLNCre(–):Girk1fl/fl (n = 6) and SLNCre(+):Girk1fl/fl (n = 5) mice (∗P < 0.05), but no difference between MLC2VCre(–):Girk1fl/fl (n = 6) and MLC2VCre(+):Girk1fl/fl
(n = 8) mice (P = 0.14).
channels (Coote, 2013; Gordan et al., 2015). While previous
studies have suggested that GIRK channels, ICa,L, and If mediate
the muscarinic receptor-dependent effects of parasympathetic
activation on the heart, their relative contributions remain
unclear. Here, we demonstrate that the impact of direct VNS on
HR, HRV, and arrhythmogenesis in anesthetized mice is mediated
primarily by the muscarinic receptor-dependent activation of
atrial GIRK channels. Notably, this study is the first to evaluate
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the impact of GIRK channel ablation, either in whole-heart or in
tissue-specific fashion, on the effects of direct VNS in mice.
Constitutive Girk1−/− and Girk4−/− mice display blunted
HR and HRV responses to pharmacologic treatments that
stimulate or mimic parasympathetic activity (Wickman et al.,
1998; Kovoor et al., 2001; Bettahi et al., 2002; Mesirca et al., 2013).
However, the degree of bradycardia conferred by GIRK channel
activation that has been reported in these studies has varied.
For example, the bradycardic effect evoked by methoxamine
activation of the baroreflex was ∼50% smaller in Girk4−/− mice
(Wickman et al., 1998; Bettahi et al., 2002), whereas experiments
involving direct perfusion of ACh onto SA nodal tissue, or of
isolated mouse hearts, have suggested that the GIRK channel
contribution to the bradycardic effect of cholinergic agonists is
concentration-dependent (Mesirca et al., 2013). Consistent with
this premise, DiFrancesco et al. (1989) showed a concentration-
dependent effect of ACh in modulation of If and IKACh in
SAN cells: whereas nanomolar concentrations of ACh inhibited
If, 20-fold higher concentrations were required to activate
IKACh.
In this study, we found that nearly all of the HR and
HRV response to electrical stimulation of the vagus nerve
was absent in constitutive Girk4−/− mice, and in mice
lacking only atrial GIRK channels. Atropine blocked VNS-
induced HR and HRV responses, indicating that these effects
are dependent on muscarinic receptor activation. While the
prominent contribution of GIRK channels revealed in this study
could reflect our utilization of a relatively strong VNS protocol,
or the fact that all recordings were made in anesthetized mice,
it was nevertheless surprising that minimal residual impact of
VNS stimulation on HR or HRV was observed in Girk4−/−
mice and SLNCre(+):Girk1fl/fl mice. Given that ICa,L and If
conductances have been recorded in SAN cells from Girk4−/−
mice (Mesirca et al., 2013), and that residual cholinergic-induced
bradycardia was seen in Girk4−/− mice (Wickman et al., 1998;
Bettahi et al., 2002; Mesirca et al., 2013; Anderson et al.,
2018), we do not believe that the lack of VNS-induced effects
in Girk4−/− or SLNCre(+):Girk1fl/fl mice reflects a loss of
muscarinic receptor expression and/or function. Notably, our
findings are consistent with those of a recent study showing that
while knockdown of HCN4 exaggerated the bradycardic response
to VNS in mice, over-expression of HCN4 only blunted VNS-
induced bradycardia in the presence of isoproterenol (Kozasa
et al., 2018). Thus, muscarinic-dependent activation of atrial
GIRK channels appears to play the primary role in the effect of
VNS on HR dynamics, at least in the anesthetized mouse.
The VNS-induced reduction of atrial effective refractory
period and increase in heterogeneity throughout the atria has
been linked to atrial arrhythmogenesis (Prystowsky et al., 1983;
Zhang and Mazgalev, 2011; Shen and Zipes, 2014). Indeed,
VNS is frequently utilized for the induction and maintenance
of atrial fibrillation in large mammalian species (Katsouras
et al., 2009; Zhang and Mazgalev, 2011). Additionally, high
vagal tone is associated with various bradyarrhythmias, including
atrioventricular block and sinus node dysfunction, in human
patients (Aksu et al., 2018). Here, we demonstrated that VNS
is also pro-arrhythmic in the mouse, as arrhythmic episodes
were only observed during VNS. Moreover, the arrhythmogenic
effect of VNS in the anesthetized mouse is primarily attributable
to the muscarinic receptor-dependent activation of atrial GIRK
channels.
VNS has been shown to exhibit anti-inflammatory effects
by decreasing pro-inflammatory and/or increasing anti-
inflammatory cytokine levels in various animal models (Zhang
et al., 2009; Calvillo et al., 2011; Mihaylova et al., 2012). Thus,
it will be interesting to test whether VNS confers a therapeutic
benefit in heart diseases characterized by pro-inflammatory
cytokines (Hedayat et al., 2010). In addition, although GIRK
channel activation appears to mediate most of the VNS-
induced influence on HR dynamics, further studies are needed
to discern whether VNS-induced activation of atrial GIRK-
channels underlies its cardioprotective benefit in diseases such
as heart failure. As part of this effort, experiments should be
conducted to determine whether it is possible to identify VNS
parameters that deliver therapeutic benefits without promoting
arrhythmogenesis.
Notably, neither Girk4−/− nor SLNCre(+):Girk1fl/fl mice
exhibited arrhythmic episodes during VNS. These findings are
consistent with a previous report showing that Girk4 ablation
confers resistance to pacing-induced atrial fibrillation in mice
(Kovoor et al., 2001), and can restore normal cardiac rhythm in
mouse models of sick sinus syndrome and AV block (Mesirca
et al., 2014, 2016). Interestingly, a recent study reported that
increased GIRK channel activity secondary to a mutation in
the gene encoding the G protein β2 subunit (Gβ2; GNB2) is
associated with AV nodal dysfunction in humans (Stallmeyer
et al., 2017). Collectively, these insights highlight the clinical
potential of pharmacologic or genetic suppression of atrial GIRK
channels for the treatment of supraventricular arrhythmias.
In summary, we conclude that the muscarinic receptor-
dependent activation of atrial GIRK channels is the
dominant mediator of VNS-induced effects on HR, HRV,
and arrhythmogenesis in mice. Our findings highlight the
potential therapeutic benefit of selectively targeting this branch
of the parasympathetic signaling for the management of atrial
arrhythmias.
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